UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 000-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) (State or ...

IDEXX William Blair 39th Annual Growth Stock Conference Jonathan Ayers, Chairman and Chief Executive Officer June 5, 2019 Preventive Care KOL Summit January 23, 2019 Safe Harbor Disclaimer The following information contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are subject to ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 000-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) DELA ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2019 Earnings Conference Call May 1, 2019 8:30 AM ET Company Participants Brian McKeon – Chief Financial Officer Jon Ayers – Chief Executive Officer Conference Call Participants Ryan Daniels – William Blair Erin Wright – Credit Suisse Michael Ryskin – Bank of America Jon Block – Stifel Mark Massaro – Canaccord Genuity Andrew Cooper – Raymond James Operator Good morning, and welcome to the IDEXX Laboratories First Quarter 2019 Earnings Conference Call. As a reminder, ...

(Mark One) T ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 0-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) DELAWARE (State ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2018 Earnings Conference Call February 1, 2019 8:30 AM ET Company Participants Jonathan Ayers - President & CEO Brian McKeon - EVP & CFO Conference Call Participants Ryan Daniels - William Blair Erin Wright - Credit Suisse Michael Ryskin - Bank of America Merrill Lynch John Block - Stifel Mark Massaro - Canaccord Genuity David Westenberg - Guggenheim Securities Operator Good morning, and welcome to the IDEXX Laboratories Fourth Quarter 2018 Earnings Conference Call. ...